Hutchmed Share Price (HCM)

Sorry the reference to HCM should be FRUSICA-1

gsk has submitted a supplementary biologics application to be assessed by 24/08/24 by fda, this seems to cover a similar population to the endometrial cancer submission for fru*****inib + sintilimab.

the gsk study is called ruby, the results of both studies are to be published. as i follow both companies i will update when more is known.

Its very likely UK and Eurozone along with Asia will end up with declining interest rates on the back of receding inflation, US being the odd dude out.

Its a long time since this scenario last played out, but given the chronic undervaluation's of UK stocks this can only act as a tailwind ..

FTSE once again pushes through 8000 mark, several global markets making new highs too!

Its a bull run in all but name..

I think the BB rules may be different in HK, I think there is a mandate in the company articles that allows the Board to make a BB and to hold shares in treasury…..they do this to meet share options and other staff awards rather than just issue new shares and this is relatively minor in terms of $ values.

I assume that a major BB program would need to be announced to the market and purchases disclosed regularly…they would also need to buy from CKHH in a connected transaction to maintain the % holding so it would be quite a complex disclosure environment and would not happen quietly….